Sign In
Upcoming Event
Free Newsletter
From left, CT technologists Amelia Richardson, Logan Raiger, Ashley Wenrich, and Lori Derr celebrate UPMC Imaging Services at Lititz being designated as a Center of Excellence by GO2 for Lung Cancer. PHOTO/PROVIDED BY UPMC
Lancaster County UPMC recognized for excellence in lung cancer screening
Listen to this articleLancaster County UPMC Imaging Services have been recognized for excellence in lung cancer screening.
UPMC Imaging Services at Lititz and Lancaster have been designated as Centers of Excellence by GO2 for Lung Cancer for providing Lancaster County with patient-centered, evidence-based lung-cancer screenings.
“Lung cancer is devastating, but early diagnosis can be the lifesaving difference,” Deborah Willwerth, MSN, RN, president and chief nursing officer, UPMC Lititz said in a statement. “UPMC is committed to improving our community’s health by making high-quality screening accessible across Central Pennsylvania. This recognition is a testament to our staff’s dedication to delivering expert care and our continued goal of growth and innovation in lung cancer care.”
According to a release, GO2 Centers of Excellence (COEs) designated in lung cancer screening are committed to facilitating patient-centered communication and decision-making. Per the release, COEs implement screening that is in accordance with current evidence and clinical guidelines from organizations such as the American College of Radiology and the National Comprehensive Network, while using a multidisciplinary approach to coordinate follow-up care, diagnostics and treatment.
“We are proud to have UPMC Imaging Services in Lancaster and Lititz join the community of GO2 for Lung Cancer Centers of Excellence,” said GO2 Chief Healthcare Delivery Officer Joelle Fathi. “A majority of people in the US living with or at risk for lung cancer are served by local community hospitals. Through GO2 COE network, we are working to foster and support collaboration and the sharing of knowledge needed to bring national and global advancements in early detection, treatment and care close to home.”
Lung cancer is a leading cause of cancer deaths in the United States. Each year, an estimated 237,000 Americans are diagnosed with lung cancer. Most of the diagnoses are discovered at the advanced stage of the disease. Providing individuals at high risk with screening that uses low-dose computed tomography helps to diagnose lung cancer when it is more treatable and potentially curable.
